MicroRNA Expression and Clinical Outcome of Small Cell Lung CancerReportar como inadecuado




MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

The role of microRNAs in small-cell lung carcinoma SCLC is largely unknown. miR-34a is known as a p53 regulated tumor suppressor microRNA in many cancer types. However, its therapeutic implication has never been studied in SCLC, a cancer type with frequent dysfunction of p53. We investigated the expression of a panel of 7 microRNAs miR-21, miR-29b, miR-34a-b-c, miR-155, and let-7a in 31 SCLC tumors, 14 SCLC cell lines, and 26 NSCLC cell lines. We observed significantly lower miR-21, miR-29b, and miR-34a expression in SCLC cell lines than in NSCLC cell lines. The expression of the 7 microRNAs was unrelated to SCLC patients- clinical characteristics and was neither prognostic in term of overall survival or progression-free survival nor predictive of treatment response. Overexpression or downregulation of miR-34a did not influence SCLC cell viability. The expression of these 7 microRNAs also did not predict in vitro sensitivity to cisplatin or etoposide in SCLC cell lines. Overexpression or downregulation of miR-34a did not influence sensitivity to cisplatin or etoposide in SCLC cell lines. In contrast to downregulation of the miR-34a target genes cMET and Axl by overexpression of miR-34a in NSCLC cell lines, the intrinsic expression of cMET and Axl was low in SCLC cell lines and was not influenced by overexpression of miR-34a. Our results suggest that the expression of the 7 selected microRNAs are not prognostic in SCLC patients, and miR-34a is unrelated to the malignant behavior of SCLC cells and is unlikely to be a therapeutic target.



Autor: Jih-Hsiang Lee, Johannes Voortman, Anne-Marie C. Dingemans, Donna M. Voeller, Trung Pham, Yisong Wang, Giuseppe Giaccone

Fuente: http://plos.srce.hr/



DESCARGAR PDF




Documentos relacionados